Author:
Yanez Betina,Czech Katherine A.,Buitrago Diana,Smith Justin D.,Schueller Stephen M.,Taub Chloe J.,Kircher Sheetal,Garcia Sofia F.,Bass Michael,Mercer Ambrosine M.,Silvera Carlos A.,Scholtens Denise,Peipert John Devin,Psihogios Alexandra M.,Duffecy Jennifer,Cella David,Antoni Michael H.,Penedo Frank J.
Funder
National Cancer Institute
National Center for Advancing Translational Sciences
Northwestern University
National Institutes of Health
Subject
Pharmacology (medical),General Medicine
Reference65 articles.
1. Depression in the US household population, 2009–2012;Pratt;NCHS Data Brief.,2016
2. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age;Linden;J. Affect. Disord.,2012
3. The prevalence and pharmacotherapy of depression in cancer patients;Ng;J. Affect. Disord.,2011
4. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies;Mitchell;Lancet Oncol.,2011
5. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments;Krebber;Psychooncology,2014